Ascendis Pharma A/S vs International Business Machines Corp — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while International Business Machines Corp trades at $237.4 (market cap $224.62B). The key difference: International Business Machines Corp is far larger — about 13.5× Ascendis Pharma A/S's market cap, and International Business Machines Corp pays a 2.84% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | IBM | |
|---|---|---|
Market Cap | $16.67B | $224.62B |
Sector | Health | Technology |
52-Week High | $277.18 | $329.23 |
52-Week Low | $189.74 | $205.77 |
Enterprise Value | $17.04B | $281.76B |
Volume | — | 4,481,527 |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →